{"id":87440,"date":"2013-09-04T12:47:32","date_gmt":"2013-09-04T16:47:32","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/bg-medicine-inc-to-present-at-the-baird-2013-health-care-conference.php"},"modified":"2013-09-04T12:47:32","modified_gmt":"2013-09-04T16:47:32","slug":"bg-medicine-inc-to-present-at-the-baird-2013-health-care-conference","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/bg-medicine-inc-to-present-at-the-baird-2013-health-care-conference.php","title":{"rendered":"BG Medicine, Inc. to Present at the Baird 2013 Health Care Conference"},"content":{"rendered":"

WALTHAM, Mass., Sept. 4, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD), a commercial stage company that is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders, announced today that Dr. Paul Sohmer, BG Medicine's President and CEO, will be presenting at the Baird 2013 Health Care Conference on September 10, 2013, at The New York Palace, beginning at 2:20 PM Eastern Time (ET). <\/p>\n

Audio and slides of BG Medicine's presentation will be webcast at: http:\/\/wsw.com\/webcast\/baird35\/BGMD<\/a>. The webcast will be archived for 30 days following the live presentation on BG Medicine's Investor Relations website at ir.BG-medicine.com. <\/p>\n

About BG Medicine <\/p>\n

BG Medicine, Inc. (BGMD) is a commercial stage company that is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit http:\/\/www.BG-medicine.com<\/a> and http:\/\/www.galectin-3.com<\/a>. The BG Medicine Inc. logo is available for download here <\/p>\n<\/p>\n

<\/p>\n

View post:<\/p>\n

BG Medicine, Inc. to Present at the Baird 2013 Health Care Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

WALTHAM, Mass., Sept. 4, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-87440","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/87440"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=87440"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/87440\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=87440"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=87440"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=87440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}